Five-Ring Circus

In the shadow-world, some accusations actually constitute an implicit admission of guilt on the part of the accuser himself.   That’s because one chapter of the secret playbook circulating among the international brotherhood of villains, thieves and scoundrels has long advocated a preemptive defense-by-offense:  accuse your adversary of precisely the sins you yourself have committed.  Your opponent will then be occupied with protesting his own innocence, and thus be unable to credibly accuse the (more) guilty party.   Some readers may be acquainted with this strategem in its quasi-blasphemous, axiomatic formulation:  “Do unto others before they do unto you.

Is Lunghu referring to the Herman Cain affair?  Nope.  Instead, he’s noting the recent remarks of Britain’s Olympic Games pointman:

Colin Moynihan, chairman of the British Olympic Association, claims the World Anti-Doping Agency has failed to achieve its objectives since its creation 10 years ago. He calls for a “fundamental review” and independent audit of the Montreal-based body.  “Never have the sanctions against the hard-line cheats been so weak since the end of the Cold War.”


To Lunghu, this level of invective (coming as it does in the months before Britain’s make-or-break London Olympics) should not necessarily be taken at face value.   Instead, Moynihan’s polemic may be an indication that the WADA is coming uncomfortably close to uncovering the specific characteristics of doping technology that’s been circulating among the top-tier Commonwealth nations (Britain, Australia and Canada) during the past few years.   Lunghu doesn’t know whether the relevant mechanisms involve oxygen uptake, metabolic enhancement, muscle-fiber regeneration or all of the above, but something has been rotten in the Anglo-sphere for at least five years now.  Is the good ole USA in on this action?  Lunghu doesn’t think so:  we’ve got our own pharmaceutical industry to rely upon.

So one wonders — does this have anything to do with WADA’s long-term agreement with GlaxoSmithKline (signed June 2011) to share information about chemical compounds identified in early-stage pharmaceutical research?

The World Anti-Doping Agency (WADA) has signed a long-term agreement with GlaxoSmithKline (GSK) that will help the agency create early detection methods for medicines that have performance-enhancing potential in sport.  The historic partnership, which was officially ratified in London on June 21, will see GSK supply WADA with confidential information about medicines in early stage development that could be abused by athletes once they are licensed for appropriate patient use.

In fact, the more plausible doping scenario would be “leakage” of experimental compounds from the lab to the locker room before “they are licensed for appropriate patient use” (and thus before any detection mechanisms are devised).   This is probably what has actually been occurring in Britain and elsewhere.   The threat to the sports doping industry is that the WADA-GSK contagion may spread:  other pharmaceutical research firms may follow GSK’s lead and sign similar agreements with WADA.  This is exactly what WADA has in mind:  take a look at Objective #6/Strategy # 2 in their strategic plan (note page 13 as well).

Let the Games begin!  May the best biochemist win!


Tags: , , , , ,

%d bloggers like this: